//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...






Voici un lien audio de vulgarisation scientifique (5min en français): open.spotify.com/show/4gGV2WU...
Glad to share our work about resistance to immunotherapy! We discovered a combination therapy allowing to eliminate 100% of MMRd CRC tumors and >70% or MMRp CRC tumors. We also identified the T cell and macrophage subsets mediating the response. Thanks to the team! www.biorxiv.org/content/10.1...
@sinaiimmuno.bsky.social
@francoisrousset.bsky.social will give a talk at Mount Sinai Hospital on May 7th. If interested, please do not hesitate to reach out!
Glad to share our work about resistance to immunotherapy! We discovered a combination therapy allowing to eliminate CRC tumors. We also identified the T cell and macrophage subsets mediating the response. Thanks to the team! www.cell.com/cell-reports... Plus, a small cartoon summarizing the study.
Here’s a short audio with accessible explanations of our findings (in English and French): open.spotify.com/show/4gGV2WU...
We're excited to share our latest work: "Targeting neoantigens conserved across organs and species overcomes tumor immune escape"! Thanks to the team at @sinaiimmuno.bsky.social ! www.biorxiv.org/content/10.1...
1mo
Feb 18, 2025
Feb 18, 2025
Apr 15, 2025
1mo
1mo
8mo